A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the ...
President Donald Trump launched TrumpRx, a program to buy cost-effective medicine, at the White House Feb. 5. Here's what to ...
At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain ...
FDA vouchers are normally a coveted prize for biopharma companies, but a surprise rejection for Disc Medicine’s rare disease drug has biopharma reconsidering.
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...
Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
2d
Dr. Dayan Goodenowe Announces FDA Clinical Development Program for a Novel Alzheimer’s Therapeutic
Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results